JP2005500373A - モルヒネ様オピオイド化合物の誘導体 - Google Patents
モルヒネ様オピオイド化合物の誘導体 Download PDFInfo
- Publication number
- JP2005500373A JP2005500373A JP2003519071A JP2003519071A JP2005500373A JP 2005500373 A JP2005500373 A JP 2005500373A JP 2003519071 A JP2003519071 A JP 2003519071A JP 2003519071 A JP2003519071 A JP 2003519071A JP 2005500373 A JP2005500373 A JP 2005500373A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- group
- substituted
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- WZLPIIWIMSEPGR-UHFFFAOYSA-N OC1C=CC(C(C2)N(CC3)/C(/Nc4ccccc4)=N/c4ccccc4)C33c4c2ccc(O)c4OC13 Chemical compound OC1C=CC(C(C2)N(CC3)/C(/Nc4ccccc4)=N/c4ccccc4)C33c4c2ccc(O)c4OC13 WZLPIIWIMSEPGR-UHFFFAOYSA-N 0.000 description 2
- 0 C*C(N**)=* Chemical compound C*C(N**)=* 0.000 description 1
- OQVOOZLLNFLSMJ-VODGNLECSA-N Cc1ccc(CC/C=C(/NC(CC[C@]23c4c(C5)ccc(O)c4O[C@H]22)[C@H]5C3C=C[C@@H]2O)\Nc2ccc(C)cc2)cc1 Chemical compound Cc1ccc(CC/C=C(/NC(CC[C@]23c4c(C5)ccc(O)c4O[C@H]22)[C@H]5C3C=C[C@@H]2O)\Nc2ccc(C)cc2)cc1 OQVOOZLLNFLSMJ-VODGNLECSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
- C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
- C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPR6938A AUPR693801A0 (en) | 2001-08-10 | 2001-08-10 | Therapeutic compounds |
| AUPR9640A AUPR964001A0 (en) | 2001-12-19 | 2001-12-19 | Therapeutic compounds |
| PCT/AU2002/001088 WO2003014122A1 (en) | 2001-08-10 | 2002-08-09 | Derivatives of morphine-like opioid compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005500373A true JP2005500373A (ja) | 2005-01-06 |
| JP2005500373A5 JP2005500373A5 (cg-RX-API-DMAC7.html) | 2006-01-05 |
Family
ID=25646773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003519071A Abandoned JP2005500373A (ja) | 2001-08-10 | 2002-08-09 | モルヒネ様オピオイド化合物の誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7199129B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1423392B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005500373A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE341552T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2002322169B2 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60215195T2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003014122A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040204862A1 (en) * | 2003-04-11 | 2004-10-14 | Wainer Irving W. | Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors |
| TWI630208B (zh) | 2008-12-08 | 2018-07-21 | 歐陸斯迪公司 | 二氫羥戊甲嗎啡 |
| US9351973B2 (en) | 2011-09-22 | 2016-05-31 | Merck Sharp & Dohme Corp. | Pyrazolopyridyl compounds as aldosterone synthase inhibitors |
| WO2013043518A1 (en) | 2011-09-22 | 2013-03-28 | Merck Sharp & Dohme Corp. | Imidazopyridyl compounds as aldosterone synthase inhibitors |
| EP2757883B1 (en) | 2011-09-22 | 2021-01-13 | Merck Sharp & Dohme Corp. | Triazolopyridyl compounds as aldosterone synthase inhibitors |
| WO2014015157A2 (en) | 2012-07-19 | 2014-01-23 | Philadelphia Health & Education Corporation | Novel sigma receptor ligands and methods of modulating cellular protein homeostasis using same |
| GB201309654D0 (en) | 2013-05-30 | 2013-07-17 | Euro Celtique Sa | Method |
| US9920836B2 (en) * | 2013-10-18 | 2018-03-20 | Kabushiki Kaisha Riken | Piston ring for internal combustion engine |
| US11117870B2 (en) | 2017-11-01 | 2021-09-14 | Drexel University | Compounds, compositions, and methods for treating diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3341538A (en) * | 1965-06-18 | 1967-09-12 | Geigy Chem Corp | Certain 2, 6-methano-3-benzazocines |
| WO1999038869A1 (en) | 1998-01-29 | 1999-08-05 | Monash University | Therapeutic compounds |
| KR100602929B1 (ko) * | 2000-08-31 | 2006-07-20 | 에프. 호프만-라 로슈 아게 | 알파-1 아드레날린성 길항제로서 퀴나졸린 유도체 |
-
2002
- 2002-08-09 AU AU2002322169A patent/AU2002322169B2/en not_active Ceased
- 2002-08-09 JP JP2003519071A patent/JP2005500373A/ja not_active Abandoned
- 2002-08-09 DE DE60215195T patent/DE60215195T2/de not_active Expired - Fee Related
- 2002-08-09 EP EP02753923A patent/EP1423392B1/en not_active Expired - Lifetime
- 2002-08-09 US US10/486,536 patent/US7199129B2/en not_active Expired - Fee Related
- 2002-08-09 AT AT02753923T patent/ATE341552T1/de not_active IP Right Cessation
- 2002-08-09 WO PCT/AU2002/001088 patent/WO2003014122A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003014122A1 (en) | 2003-02-20 |
| EP1423392A4 (en) | 2004-11-17 |
| ATE341552T1 (de) | 2006-10-15 |
| US20040242616A1 (en) | 2004-12-02 |
| DE60215195D1 (de) | 2006-11-16 |
| US7199129B2 (en) | 2007-04-03 |
| DE60215195T2 (de) | 2007-08-23 |
| EP1423392A1 (en) | 2004-06-02 |
| EP1423392B1 (en) | 2006-10-04 |
| AU2002322169B2 (en) | 2008-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6794602B2 (ja) | ポリアミド化合物及びその使用 | |
| KR102038260B1 (ko) | 히드로코돈의 벤조산, 벤조산 유도체 및 헤테로아릴 카르복실산 콘쥬게이트, 이의 전구약물, 제조 방법 및 용도 | |
| US8871780B2 (en) | Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, method of making and use thereof | |
| US6784186B1 (en) | Therapeutic compounds | |
| KR20090086627A (ko) | 프로드러그 및 그것의 제조 및 사용 방법 | |
| CN104812388A (zh) | 新型化合物、其合成及其用途 | |
| KR20150065873A (ko) | 케타민 유도체 | |
| CN102341389A (zh) | 含氟化合物和其使用方法 | |
| EP1423392B1 (en) | Derivatives of morphine-like opioid compounds | |
| JP6013345B2 (ja) | 痛み治療用の4,5a−エポキシモルフィナンの6−アミド誘導体 | |
| AU2002322169A1 (en) | Derivatives of morphine-like opioid compounds | |
| ITFI20100001A1 (it) | Composti ad efficacia sia analgesica che antiperalgesica. | |
| US20060111381A1 (en) | Amidine compounds | |
| JP2005500373A5 (cg-RX-API-DMAC7.html) | ||
| JP2022539197A (ja) | Nmda受容体の調節因子 | |
| AU2003266841A1 (en) | Amidine compounds | |
| JPH0262544B2 (cg-RX-API-DMAC7.html) | ||
| AU757975C (en) | Therapeutic compounds | |
| TW399056B (en) | Long analgesic acting nalbuphine polyester derivative and method of use | |
| US20060217414A1 (en) | High affinity ligands for nociceptin receptor ORL-1 | |
| HK40100661A (en) | Phosphonates as inhibitors of enpp1 and cdnp | |
| TW201540714A (zh) | N-經取代之降伊波加因鹼(noribogaine)前藥 | |
| WO2013043558A1 (en) | Compositions and methods for treating cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050805 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050805 |
|
| A762 | Written abandonment of application |
Free format text: JAPANESE INTERMEDIATE CODE: A762 Effective date: 20060117 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20060117 |